(202) 558-2030 info@nidellaw.com

SSRI & SNRI Antidepressant Use During Preganancy

Evidence links to Autism and ASD Related Injuries

 

 SSRI and SNRI Antidepressant Use Increase Risk of Autism and ASD in Offspring

New evidence published in the Journal of the American Medical Association Pediatrics provides further confirmation of a link between antidepressant usage by mothers during pregnancy and the increased risk for autism and ASD-related injuries in maternal offspring.  The list of relevant drugs includes is provided below.  If you were prescribed one or more of these drugs while pregnant and have a child suffering from autism or a related injury, please CONTACT US by filling out the form below.

  • Celexa®
  • Lexapro®
  • Prozac®
  • Luvox®
  • Paxil®
  • Zoloft®
  • Pristine®
  • Cymbalta®
  • Effexor®/Effexor XR®
  • Savella®
  • Fetzima®

The conclusions section from the abstract of the study is shown below and the article can be found here:

Conclusions and Relevance  Use of antidepressants, specifically selective serotonin reuptake inhibitors, during the second and/or third trimester increases the risk of ASD in children, even after considering maternal depression. Further research is needed to specifically assess the risk of ASD associated with antidepressant types and dosages during pregnancy.

This study further builds on mounting evidence of the link between ASD and maternal antidepressant usage.   Last year, a research paper published by scientists at the Johns Hopkins Bloomberg School of Public Health provided evidence of a connection between pregnant mothers use of certain type of medications, known as selective seratonin reuptake inhibitors or “SSRIs”, used in the treatment of depression, anxiety, and other medical conditions, and an increased risk for offspring with autism spectrum disorder or ASD.  This study demonstrated that the greatest risk is associated with prenatal SSRI use during the first trimester of pregnancy, where the risk of having an autistic boy was nearly 3-times greater than for those mothers that were not given the medication.

Now there is evidence that these drugs may lead to an increased risk of ASD disorders in all three trimesters of fetal development.

We are now in the final stages of evaluating the evidence supporting filing lawsuits against the manufacturers of these drugs for failing to identify and warned these risks.

If you are a parent with a child that has been diagnosed with an autism spectrum condition and believe that it may be attributable to the use of an SSRI or SNRI antidepressant during pregnancy, we ask that you please complete the following form.

You may have a claim against the manufacturers or distributors of these potentially dangerous drugs.  Fill out the following form for a FREE CONSULTATION.

Environmental Health News

Our reporting team in the US heard numerous warnings about the lessons that should be learnt, and di [...]

An industry-sponsored bill to change the process by which asbestos victims sue for damages moves ahe [...]

Colombia's Constitutional Court has ordered the resumption of aerial fumigation of illicit crop [...]

The mother of a boy born with birth defects allegedly caused by pesticide exposure cried on the witn [...]

The oil company behind the Dakota Access pipeline is facing intense scrutiny from regulators and act [...]

Canada is moving ahead with plans to stop a potent form of air pollution made by fossil fuel compani [...]

A growing number of consumers are rejecting chemical-filled cosmetics for pricey, plant-based altern [...]

Central Oregon pediatricians take vastly different approaches to checking kids for lead exposure. [...]

New data from the health department reveals that 32 infants were born in the city to 402 women infec [...]

The CDC report estimates that 13.8 million Americans could be living with Alzheimer's by 2050. [...]